SEC Info - Garbacz Stephen - ‘3’ for 10/1/14 re: Epizyme, Inc.

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Garbacz Stephen

(Last)

(First)

(Middle)

C/O EPIZYME, INC.

400 TECHNOLOGY SQUARE

(Street)

CAMBRIDGE

02139

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/1/14

3. Issuer Name and Ticker or Trading Symbol
Epizyme, Inc. [ EPZM ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Principal Accounting Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.0001 per share	13,073	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽¹⁾	10/2/22	Common Stock	23,438	2.19	D
Stock Option (Right to Buy)	⁽²⁾	1/24/23	Common Stock	18,745	3.54	D
Stock Option (Right to Buy)	⁽³⁾	9/2/23	Common Stock	15,000	28.04	D
Stock Option (Right to Buy)	⁽⁴⁾	1/27/24	Common Stock	14,000	31.2	D

Explanation of Responses:

(1) This option was granted on October 3, 2012 with respect to 41,666 shares of Common Stock, with 25% vesting on October 3, 2013 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.

(2) This option was granted on January 25, 2013 with respect to 25,700 shares of Common Stock, with 25% vesting on January 25, 2014 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.

(3) This option was granted on September 3, 2013 with respect to 15,000 shares of Common Stock, with 25% vesting on September 3, 2014 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.

(4) This option was granted on January 28, 2014 with respect to 14,000 shares of Common Stock, with 25% vesting on January 28, 2015 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.

Remarks:

	/s/ Stephen Garbacz	10/1/14
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Garbacz Stephen – ‘3’ for 10/1/14 re: Epizyme, Inc.

On: Wednesday, 10/1/14, at 9:41pm ET · For: 10/1/14 · As: Officer · Accession #: 1209191-14-60760 · File #: 1-35945

Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 — SEA’34
Filing Table of Contents

‘3’ — Form 3 Submission — doc3.xml/2.6

This ‘3’ Document is an XML Data File that may be rendered in various formats:

Garbacz Stephen – ‘3’ for 10/1/14 re: Epizyme, Inc.

On: Wednesday, 10/1/14, at 9:41pm ET · For: 10/1/14 · As: Officer · Accession #: 1209191-14-60760 · File #: 1-35945

Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 — SEA’34Filing Table of Contents

‘3’ — Form 3 Submission — doc3.xml/2.6

This ‘3’ Document is an XML Data File that may be rendered in various formats:

Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 — SEA’34
Filing Table of Contents